ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank C. Detterbeck
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detterbeck, F. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Detterbeck, F. C.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2003;76:1832
© 2003 The Society of Thoracic Surgeons

Invited commentary

Frank C. Detterbeck, MD

Division of Cardiothoracic SurgeryUniversity of North Carolina at Chapel HillCB #7065Medical School Wing C, Room 354 Chapel Hill, NC 27599-7065 USA

e-mail: fdetter@med.unc.edu

The first 20% of the full text of this article appears below.

At the beginning of this new millennium, many established concepts are being seriously questioned, such as the idea that there is no role for screening for lung cancer; that all non-small cell lung cancers (NSCLC) behave more or less the same; and that lobectomy is the procedure of choice for an early NSCLC. Although we are accustomed to looking for progress in the form of new technology or medications, history shows us that a . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.